ReviewPLoS pathogens2026
Decoding the complex receptor landscape of enterovirus D68.
Review in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterovirus D68 (EV-D68) is an emerging pathogen associated with severe respiratory diseases and central nervous system complications. This pearl summarizes the roles of glycan receptors, such as sialic acid, and protein receptors like ICAM-5 and MFSD6 in EV-D68 infection. MFSD6 serves as a primary receptor due to its widespread distribution in tissues, while sialic acid and ICAM-5 play a synergistic role in facilitating invasion across various tissues. We have elaborated on the correlation between receptor distribution, tissue tropism, and pathogenicity. The complex receptor system of EV-D68 enhances its pathogenicity by facilitating multi-tissue invasion and allowing the virus to adapt to various microenvironments. This adaptability provides insights into distinct receptor preferences and their associations with pathogenic outcomes, where specific receptor binding can influence the severity of infection. Additionally, we discuss the effectiveness of receptor-targeted inhibitors and the potential for therapeutic interventions aimed at disrupting receptor-virus interactions. Our pearl underscores the multifaceted nature of EV-D68 receptors and their implications for the development of novel antiviral strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.